PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, making personalized GLP-1 therapy accessible without insurance barriers
Lopez-Alarcon M, Perichart-Perera O, Flores-Huerta S, et al
The new vertical is launching in 20 states this week, including Colorado, Massachusetts, Michigan, Nevada and New York, with plans to expand to the rest of the country by the end of 2024
Needle: The needle attaches to the syringe and is used to inject the B12 solution into the muscle tissue
This patient-centered approach aligns with PlexusDx's precision health model, where semaglutide dosing and formulation type can be personalized without increasing your monthly cost